Group designation | Sex | Number of mice | Surgery | Dose of androgen (mg/tube) | CTA (CSÂ +Â US) |
---|---|---|---|---|---|
Experiment 2 | |||||
 Sex groups | Male | 7 | Intact | – | Sac + LiCl |
Female | 6 | Intact | – | Sac + LiCl | |
Experiment 3 | |||||
 T-dose groups | Male | 9 | Gonadectomy | 0 | Sac + LiCl |
Male | 4 | Gonadectomy | 0.2 | Sac + LiCl | |
Male | 5 | Gonadectomy | 0.5 | Sac + LiCl | |
Male | 10 | Gonadectomy | 1.0 | Sac + LiCl | |
Male | 11 | Gonadectomy | 2.0 | Sac + LiCl | |
 Non-CTA/T-dose groups | Male | 5 | Gonadectomy | 0 | Sac + NaCl |
Male | 5 | Gonadectomy | 0.5 | Sac + NaCl | |
 DHT-dose groups | Male | 5 | Gonadectomy | 0 | Sac + LiCl |
Male | 6 | Gonadectomy | 0.05 | Sac + LiCl | |
Male | 9 | Gonadectomy | 0.1 | Sac + LiCl | |
 Blood T groups | Male | 7, 8, 9, 10 weeks:3 each | Gonadectomy | 0.5 | – |
Experiment 4 | |||||
 Female T-dose groups | Female | 8 | Gonadectomy | 0 | Sac + LiCl |
Female | 10 | Gonadectomy | 0.5 | Sac + LiCl |